BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hazkani I, Motiei M, Betzer O, Sadan T, Bragilovski D, Lubimov L, Mizrachi A, Hadar T, Levi M, Ben-Aharon I, Haviv I, Popovtzer R, Popovtzer A. Can molecular profiling enhance radiotherapy? Impact of personalized targeted gold nanoparticles on radiosensitivity and imaging of adenoid cystic carcinoma. Theranostics 2017;7:3962-71. [PMID: 29109791 DOI: 10.7150/thno.19615] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Haque M, Shakil MS, Mahmud KM. The Promise of Nanoparticles-Based Radiotherapy in Cancer Treatment. Cancers (Basel) 2023;15:1892. [PMID: 36980778 DOI: 10.3390/cancers15061892] [Reference Citation Analysis]
2 Gal O, Betzer O, Rousso-Noori L, Sadan T, Motiei M, Nikitin M, Friedmann-Morvinski D, Popovtzer R, Popovtzer A. Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy. J Nanotheranostics 2022;3:177-88. [PMID: 36324626 DOI: 10.3390/jnt3040012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Huynh M, Kempson I, Bezak E, Phillips W. Predictive modeling of hypoxic head and neck cancers during fractionated radiotherapy with gold nanoparticle radiosensitization. Med Phys 2021;48:3120-33. [PMID: 33818799 DOI: 10.1002/mp.14872] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Manzari MT, Shamay Y, Kiguchi H, Rosen N, Scaltriti M, Heller DA. Targeted drug delivery strategies for precision medicines. Nat Rev Mater 2021;6:351-70. [DOI: 10.1038/s41578-020-00269-6] [Cited by in Crossref: 112] [Cited by in F6Publishing: 126] [Article Influence: 56.0] [Reference Citation Analysis]
5 Tzror-Azankot C, Betzer O, Sadan T, Motiei M, Rahimipour S, Atkins A, Popovtzer A, Popovtzer R. Glucose-Functionalized Liposomes for Reducing False Positives in Cancer Diagnosis. ACS Nano 2021;15:1301-9. [PMID: 33356143 DOI: 10.1021/acsnano.0c08530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Huynh M, Kempson I, Bezak E, Phillips W. In silico modeling of cellular probabilistic nanoparticle radiosensitization in head and neck cancers. Nanomedicine 2020;15:2837-50. [DOI: 10.2217/nnm-2020-0301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Zhai Z, Hu J, You Y, Yang X, Song Z. Tumor with slow-developing and recurring lumps of the external ear with skull base and lung metastasis: A case report. Oncol Lett 2020;20:1567-72. [PMID: 32724398 DOI: 10.3892/ol.2020.11724] [Reference Citation Analysis]
8 Lepeltier E, Rijo P, Rizzolio F, Popovtzer R, Petrikaite V, Assaraf YG, Passirani C. Nanomedicine to target multidrug resistant tumors. Drug Resist Updat 2020;52:100704. [PMID: 32512316 DOI: 10.1016/j.drup.2020.100704] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 16.0] [Reference Citation Analysis]
9 Hsu JC, Nieves LM, Betzer O, Sadan T, Noël PB, Popovtzer R, Cormode DP. Nanoparticle contrast agents for X-ray imaging applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1642. [PMID: 32441050 DOI: 10.1002/wnan.1642] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
10 Dahary D, Golan Y, Mazor Y, Zelig O, Barshir R, Twik M, Iny Stein T, Rosner G, Kariv R, Chen F, Zhang Q, Shen Y, Safran M, Lancet D, Fishilevich S. Genome analysis and knowledge-driven variant interpretation with TGex. BMC Med Genomics 2019;12:200. [PMID: 31888639 DOI: 10.1186/s12920-019-0647-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
11 Betzer O, Barnoy E, Sadan T, Elbaz I, Braverman C, Liu Z, Popovtzer R. Advances in imaging strategies for in vivo tracking of exosomes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1594. [PMID: 31840427 DOI: 10.1002/wnan.1594] [Cited by in Crossref: 30] [Cited by in F6Publishing: 38] [Article Influence: 7.5] [Reference Citation Analysis]
12 [DOI: 10.1117/12.2510353] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Motiei M, Dreifuss T, Sadan T, Omer N, Blumenfeld-katzir T, Fragogeorgi E, Loudos G, Popovtzer R, Ben-eliezer N. Trimodal Nanoparticle Contrast Agent for CT, MRI and SPECT Imaging: Synthesis and Characterization of Radiolabeled Core/Shell Iron Oxide@Gold Nanoparticles. Chem Lett 2019;48:291-4. [DOI: 10.1246/cl.180780] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
14 Wang P, Sun W, Wang Q, Ma J, Su X, Jiang Q, Sun X. Iodine-Labeled Au Nanorods with High Radiochemical Stability for Imaging-Guided Radiotherapy and Photothermal Therapy. ACS Appl Nano Mater 2019;2:1374-81. [DOI: 10.1021/acsanm.8b02229] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
15 [DOI: 10.1117/12.2287351] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
16 Fortin M, Simão T, Laprise-pelletier M. Gold Nanoparticles for Imaging and Cancer Therapy. Nanooncology 2018. [DOI: 10.1007/978-3-319-89878-0_1] [Reference Citation Analysis]